–
Nuvectis Pharma, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−12.9
FY22:
−19.2
FY23:
−22.9
FY24:
−19.8
FY25:
−27.6
(positive)
Change from FY21 to FY25
millions USD
FY21:
−12.9
FY22:
−19.2
FY23:
−22.9
FY24:
−19.8
FY25:
−27.6
(positive)
Change from FY21 to FY25
millions USD
FY21:
−12.9
FY22:
−19.1
FY23:
−22.3
FY24:
−19.0
FY25:
−26.4
(positive)
Change from FY21 to FY25
millions USD
FY21:
−12.9
FY22:
−19.1
FY23:
−22.3
FY24:
−19.0
FY25:
−26.4
All amounts in millions USD